Karin Cerna

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Flow Cytometric Detection of NK Cell KIR Receptors: a Novel Tool for Functional Profiling in Reproductive Failure.

Flow Cytometric Detection of NK Cell KIR Receptors: a Novel Tool for Functional Profiling in Reproductive Failure.

Journal: Clinical laboratory

Published: July 07, 2026

Parental KIR/HLA-C Profiles and Reproductive Failure: A Phenotype-Stratified Retrospective Analysis of Couples With Fertility Disorders.

Parental KIR/HLA-C Profiles and Reproductive Failure: A Phenotype-Stratified Retrospective Analysis of Couples With Fertility Disorders.

Journal: Obstetrics and gynecology international

Published: February 24, 2026

Clinical significance of quantification and immunophenotyping of uterine NK cells in the diagnosis and treatment of infertility.

Clinical significance of quantification and immunophenotyping of uterine NK cells in the diagnosis and treatment of infertility.

Journal: Ceska gynekologie

Published: March 21, 2025

Subcutaneous infliximab in Crohn's disease patients with previous immunogenic failure of intravenous infliximab.

Subcutaneous infliximab in Crohn's disease patients with previous immunogenic failure of intravenous infliximab.

Journal: International journal of colorectal disease

Published: September 16, 2024

Reduced number of regulatory T cells in maternal circulation precede idiopathic spontaneous preterm labor in a subset of patients.

Reduced number of regulatory T cells in maternal circulation precede idiopathic spontaneous preterm labor in a subset of patients.

Journal: American journal of obstetrics and gynecology

Published: June 21, 2024

Serological responses to vaccination in children exposed in utero to ustekinumab or vedolizumab: cross-sectional analysis of a prospective multicentre cohort.

Serological responses to vaccination in children exposed in utero to ustekinumab or vedolizumab: cross-sectional analysis of a prospective multicentre cohort.

Journal: European journal of pediatrics

Published: March 05, 2024

Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?

Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?

Journal: Crohn's & colitis 360

Published: November 29, 2023

Tofacitinib in Pregnancy: Assessing Pregnancy and Infant Outcomes, Cord Blood, and Breast Milk Concentrations.

Tofacitinib in Pregnancy: Assessing Pregnancy and Infant Outcomes, Cord Blood, and Breast Milk Concentrations.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 06, 2023

Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study.

Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study.

Journal: Expert review of gastroenterology & hepatology

Published: December 20, 2022

Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients.

Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients.

Journal: Journal of Crohn's & colitis

Published: January 16, 2022

Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study.

Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study.

Journal: Inflammatory bowel diseases

Published: September 18, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026